The global market for Alpha Galactosidase A was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Alpha Galactosidase A is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alpha Galactosidase A is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alpha Galactosidase A include Amicus Therapeutics, Inc., Greenovation Biotech GmbH, iBio, Inc., ISU ABXIS Co.,Ltd., JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc., Takeda, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha Galactosidase A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Galactosidase A.

The Alpha Galactosidase A market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha Galactosidase A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alpha Galactosidase A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alpha Galactosidase A Market Report

Report Metric	Details
Report Name	Alpha Galactosidase A Market
Segment by Type	Agalsidase Alfa AVRRD-01 Migalastat Hydrochloride MOSS-AGAL Others
Segment by Application	Hospital Clinic Home Care
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amicus Therapeutics, Inc., Greenovation Biotech GmbH, iBio, Inc., ISU ABXIS Co.,Ltd., JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc., Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alpha Galactosidase A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alpha Galactosidase A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alpha Galactosidase A Market report?

Ans: The main players in the Alpha Galactosidase A Market are Amicus Therapeutics, Inc., Greenovation Biotech GmbH, iBio, Inc., ISU ABXIS Co.,Ltd., JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc., Takeda

What are the Application segmentation covered in the Alpha Galactosidase A Market report?

Ans: The Applications covered in the Alpha Galactosidase A Market report are Hospital, Clinic, Home Care

What are the Type segmentation covered in the Alpha Galactosidase A Market report?

Ans: The Types covered in the Alpha Galactosidase A Market report are Agalsidase Alfa, AVRRD-01, Migalastat Hydrochloride, MOSS-AGAL, Others

1 Alpha Galactosidase A Market Overview

1.1 Product Definition

1.2 Alpha Galactosidase A by Type

1.2.1 Global Alpha Galactosidase A Market Value Comparison by Type (2024 VS 2031)

1.2.2 Agalsidase Alfa

1.2.3 AVRRD-01

1.2.4 Migalastat Hydrochloride

1.2.5 MOSS-AGAL

1.2.6 Others

1.3 Alpha Galactosidase A by Application

1.3.1 Global Alpha Galactosidase A Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Home Care

1.4 Global Alpha Galactosidase A Market Size Estimates and Forecasts

1.4.1 Global Alpha Galactosidase A Revenue 2020-2031

1.4.2 Global Alpha Galactosidase A Sales 2020-2031

1.4.3 Global Alpha Galactosidase A Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Alpha Galactosidase A Market Competition by Manufacturers

2.1 Global Alpha Galactosidase A Sales Market Share by Manufacturers (2020-2025)

2.2 Global Alpha Galactosidase A Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Alpha Galactosidase A Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Alpha Galactosidase A, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Alpha Galactosidase A, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Alpha Galactosidase A, Product Type & Application

2.7 Global Key Manufacturers of Alpha Galactosidase A, Date of Enter into This Industry

2.8 Global Alpha Galactosidase A Market Competitive Situation and Trends

2.8.1 Global Alpha Galactosidase A Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Alpha Galactosidase A Players Market Share by Revenue

2.8.3 Global Alpha Galactosidase A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Alpha Galactosidase A Market Scenario by Region

3.1 Global Alpha Galactosidase A Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Alpha Galactosidase A Sales by Region: 2020-2031

3.2.1 Global Alpha Galactosidase A Sales by Region: 2020-2025

3.2.2 Global Alpha Galactosidase A Sales by Region: 2026-2031

3.3 Global Alpha Galactosidase A Revenue by Region: 2020-2031

3.3.1 Global Alpha Galactosidase A Revenue by Region: 2020-2025

3.3.2 Global Alpha Galactosidase A Revenue by Region: 2026-2031

3.4 North America Alpha Galactosidase A Market Facts & Figures by Country

3.4.1 North America Alpha Galactosidase A Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Alpha Galactosidase A Sales by Country (2020-2031)

3.4.3 North America Alpha Galactosidase A Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Alpha Galactosidase A Market Facts & Figures by Country

3.5.1 Europe Alpha Galactosidase A Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Alpha Galactosidase A Sales by Country (2020-2031)

3.5.3 Europe Alpha Galactosidase A Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Alpha Galactosidase A Market Facts & Figures by Region

3.6.1 Asia Pacific Alpha Galactosidase A Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Alpha Galactosidase A Sales by Region (2020-2031)

3.6.3 Asia Pacific Alpha Galactosidase A Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Alpha Galactosidase A Market Facts & Figures by Country

3.7.1 Latin America Alpha Galactosidase A Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Alpha Galactosidase A Sales by Country (2020-2031)

3.7.3 Latin America Alpha Galactosidase A Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Alpha Galactosidase A Market Facts & Figures by Country

3.8.1 Middle East and Africa Alpha Galactosidase A Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Alpha Galactosidase A Sales by Country (2020-2031)

3.8.3 Middle East and Africa Alpha Galactosidase A Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Alpha Galactosidase A Sales by Type (2020-2031)

4.1.1 Global Alpha Galactosidase A Sales by Type (2020-2025)

4.1.2 Global Alpha Galactosidase A Sales by Type (2026-2031)

4.1.3 Global Alpha Galactosidase A Sales Market Share by Type (2020-2031)

4.2 Global Alpha Galactosidase A Revenue by Type (2020-2031)

4.2.1 Global Alpha Galactosidase A Revenue by Type (2020-2025)

4.2.2 Global Alpha Galactosidase A Revenue by Type (2026-2031)

4.2.3 Global Alpha Galactosidase A Revenue Market Share by Type (2020-2031)

4.3 Global Alpha Galactosidase A Price by Type (2020-2031)

5 Segment by Application

5.1 Global Alpha Galactosidase A Sales by Application (2020-2031)

5.1.1 Global Alpha Galactosidase A Sales by Application (2020-2025)

5.1.2 Global Alpha Galactosidase A Sales by Application (2026-2031)

5.1.3 Global Alpha Galactosidase A Sales Market Share by Application (2020-2031)

5.2 Global Alpha Galactosidase A Revenue by Application (2020-2031)

5.2.1 Global Alpha Galactosidase A Revenue by Application (2020-2025)

5.2.2 Global Alpha Galactosidase A Revenue by Application (2026-2031)

5.2.3 Global Alpha Galactosidase A Revenue Market Share by Application (2020-2031)

5.3 Global Alpha Galactosidase A Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amicus Therapeutics, Inc.

6.1.1 Amicus Therapeutics, Inc. Company Information

6.1.2 Amicus Therapeutics, Inc. Description and Business Overview

6.1.3 Amicus Therapeutics, Inc. Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amicus Therapeutics, Inc. Alpha Galactosidase A Product Portfolio

6.1.5 Amicus Therapeutics, Inc. Recent Developments/Updates

6.2 Greenovation Biotech GmbH

6.2.1 Greenovation Biotech GmbH Company Information

6.2.2 Greenovation Biotech GmbH Description and Business Overview

6.2.3 Greenovation Biotech GmbH Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Greenovation Biotech GmbH Alpha Galactosidase A Product Portfolio

6.2.5 Greenovation Biotech GmbH Recent Developments/Updates

6.3 iBio, Inc.

6.3.1 iBio, Inc. Company Information

6.3.2 iBio, Inc. Description and Business Overview

6.3.3 iBio, Inc. Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.3.4 iBio, Inc. Alpha Galactosidase A Product Portfolio

6.3.5 iBio, Inc. Recent Developments/Updates

6.4 ISU ABXIS Co.,Ltd.

6.4.1 ISU ABXIS Co.,Ltd. Company Information

6.4.2 ISU ABXIS Co.,Ltd. Description and Business Overview

6.4.3 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.4.4 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Product Portfolio

6.4.5 ISU ABXIS Co.,Ltd. Recent Developments/Updates

6.5 JCR Pharmaceuticals Co., Ltd.

6.5.1 JCR Pharmaceuticals Co., Ltd. Company Information

6.5.2 JCR Pharmaceuticals Co., Ltd. Description and Business Overview

6.5.3 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.5.4 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Product Portfolio

6.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates

6.6 Pharming Group N.V.

6.6.1 Pharming Group N.V. Company Information

6.6.2 Pharming Group N.V. Description and Business Overview

6.6.3 Pharming Group N.V. Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pharming Group N.V. Alpha Galactosidase A Product Portfolio

6.6.5 Pharming Group N.V. Recent Developments/Updates

6.7 Protalix BioTherapeutics, Inc.

6.7.1 Protalix BioTherapeutics, Inc. Company Information

6.7.2 Protalix BioTherapeutics, Inc. Description and Business Overview

6.7.3 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Product Portfolio

6.7.5 Protalix BioTherapeutics, Inc. Recent Developments/Updates

6.8 Takeda

6.8.1 Takeda Company Information

6.8.2 Takeda Description and Business Overview

6.8.3 Takeda Alpha Galactosidase A Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Takeda Alpha Galactosidase A Product Portfolio

6.8.5 Takeda Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Alpha Galactosidase A Industry Chain Analysis

7.2 Alpha Galactosidase A Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Alpha Galactosidase A Production Mode & Process Analysis

7.4 Alpha Galactosidase A Sales and Marketing

7.4.1 Alpha Galactosidase A Sales Channels

7.4.2 Alpha Galactosidase A Distributors

7.5 Alpha Galactosidase A Customer Analysis

8 Alpha Galactosidase A Market Dynamics

8.1 Alpha Galactosidase A Industry Trends

8.2 Alpha Galactosidase A Market Drivers

8.3 Alpha Galactosidase A Market Challenges

8.4 Alpha Galactosidase A Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Amicus Therapeutics Inc

greenovation Biotech GmbH

IBio Inc.

ISU ABXIS Co Ltd

JCR Pharmaceuticals Co Ltd

Pharming Group N.V.

Protalix BioTherapeutics, Inc.

Takeda

List of Tables

Table 1. Global Alpha Galactosidase A Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Alpha Galactosidase A Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Alpha Galactosidase A Market Competitive Situation by Manufacturers in 2024

Table 4. Global Alpha Galactosidase A Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Alpha Galactosidase A Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Alpha Galactosidase A Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Alpha Galactosidase A Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Alpha Galactosidase A Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Alpha Galactosidase A, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Alpha Galactosidase A, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Alpha Galactosidase A, Product Type & Application

Table 12. Global Key Manufacturers of Alpha Galactosidase A, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Alpha Galactosidase A by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Galactosidase A as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Alpha Galactosidase A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Alpha Galactosidase A Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Alpha Galactosidase A Sales Market Share by Region (2020-2025)

Table 19. Global Alpha Galactosidase A Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Alpha Galactosidase A Sales Market Share by Region (2026-2031)

Table 21. Global Alpha Galactosidase A Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Alpha Galactosidase A Revenue Market Share by Region (2020-2025)

Table 23. Global Alpha Galactosidase A Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Alpha Galactosidase A Revenue Market Share by Region (2026-2031)

Table 25. North America Alpha Galactosidase A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Alpha Galactosidase A Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Alpha Galactosidase A Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Alpha Galactosidase A Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Alpha Galactosidase A Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Alpha Galactosidase A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Alpha Galactosidase A Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Alpha Galactosidase A Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Alpha Galactosidase A Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Alpha Galactosidase A Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Alpha Galactosidase A Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Alpha Galactosidase A Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Alpha Galactosidase A Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Alpha Galactosidase A Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Alpha Galactosidase A Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Alpha Galactosidase A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Alpha Galactosidase A Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Alpha Galactosidase A Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Alpha Galactosidase A Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Alpha Galactosidase A Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Alpha Galactosidase A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Alpha Galactosidase A Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Alpha Galactosidase A Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Alpha Galactosidase A Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Alpha Galactosidase A Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Alpha Galactosidase A Sales (K Pcs) by Type (2020-2025)

Table 51. Global Alpha Galactosidase A Sales (K Pcs) by Type (2026-2031)

Table 52. Global Alpha Galactosidase A Sales Market Share by Type (2020-2025)

Table 53. Global Alpha Galactosidase A Sales Market Share by Type (2026-2031)

Table 54. Global Alpha Galactosidase A Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Alpha Galactosidase A Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Alpha Galactosidase A Revenue Market Share by Type (2020-2025)

Table 57. Global Alpha Galactosidase A Revenue Market Share by Type (2026-2031)

Table 58. Global Alpha Galactosidase A Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Alpha Galactosidase A Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Alpha Galactosidase A Sales (K Pcs) by Application (2020-2025)

Table 61. Global Alpha Galactosidase A Sales (K Pcs) by Application (2026-2031)

Table 62. Global Alpha Galactosidase A Sales Market Share by Application (2020-2025)

Table 63. Global Alpha Galactosidase A Sales Market Share by Application (2026-2031)

Table 64. Global Alpha Galactosidase A Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Alpha Galactosidase A Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Alpha Galactosidase A Revenue Market Share by Application (2020-2025)

Table 67. Global Alpha Galactosidase A Revenue Market Share by Application (2026-2031)

Table 68. Global Alpha Galactosidase A Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Alpha Galactosidase A Price (USD/Pcs) by Application (2026-2031)

Table 70. Amicus Therapeutics, Inc. Company Information

Table 71. Amicus Therapeutics, Inc. Description and Business Overview

Table 72. Amicus Therapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Amicus Therapeutics, Inc. Alpha Galactosidase A Product

Table 74. Amicus Therapeutics, Inc. Recent Developments/Updates

Table 75. Greenovation Biotech GmbH Company Information

Table 76. Greenovation Biotech GmbH Description and Business Overview

Table 77. Greenovation Biotech GmbH Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Greenovation Biotech GmbH Alpha Galactosidase A Product

Table 79. Greenovation Biotech GmbH Recent Developments/Updates

Table 80. iBio, Inc. Company Information

Table 81. iBio, Inc. Description and Business Overview

Table 82. iBio, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. iBio, Inc. Alpha Galactosidase A Product

Table 84. iBio, Inc. Recent Developments/Updates

Table 85. ISU ABXIS Co.,Ltd. Company Information

Table 86. ISU ABXIS Co.,Ltd. Description and Business Overview

Table 87. ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. ISU ABXIS Co.,Ltd. Alpha Galactosidase A Product

Table 89. ISU ABXIS Co.,Ltd. Recent Developments/Updates

Table 90. JCR Pharmaceuticals Co., Ltd. Company Information

Table 91. JCR Pharmaceuticals Co., Ltd. Description and Business Overview

Table 92. JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Product

Table 94. JCR Pharmaceuticals Co., Ltd. Recent Developments/Updates

Table 95. Pharming Group N.V. Company Information

Table 96. Pharming Group N.V. Description and Business Overview

Table 97. Pharming Group N.V. Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Pharming Group N.V. Alpha Galactosidase A Product

Table 99. Pharming Group N.V. Recent Developments/Updates

Table 100. Protalix BioTherapeutics, Inc. Company Information

Table 101. Protalix BioTherapeutics, Inc. Description and Business Overview

Table 102. Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Protalix BioTherapeutics, Inc. Alpha Galactosidase A Product

Table 104. Protalix BioTherapeutics, Inc. Recent Developments/Updates

Table 105. Takeda Company Information

Table 106. Takeda Description and Business Overview

Table 107. Takeda Alpha Galactosidase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Takeda Alpha Galactosidase A Product

Table 109. Takeda Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Alpha Galactosidase A Distributors List

Table 113. Alpha Galactosidase A Customers List

Table 114. Alpha Galactosidase A Market Trends

Table 115. Alpha Galactosidase A Market Drivers

Table 116. Alpha Galactosidase A Market Challenges

Table 117. Alpha Galactosidase A Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Alpha Galactosidase A

Figure 2. Global Alpha Galactosidase A Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Alpha Galactosidase A Market Share by Type: 2024 & 2031

Figure 4. Agalsidase Alfa Product Picture

Figure 5. AVRRD-01 Product Picture

Figure 6. Migalastat Hydrochloride Product Picture

Figure 7. MOSS-AGAL Product Picture

Figure 8. Others Product Picture

Figure 9. Global Alpha Galactosidase A Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Alpha Galactosidase A Market Share by Application: 2024 & 2031

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Home Care

Figure 14. Global Alpha Galactosidase A Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Alpha Galactosidase A Market Size (2020-2031) & (US$ Million)

Figure 16. Global Alpha Galactosidase A Sales (2020-2031) & (K Pcs)

Figure 17. Global Alpha Galactosidase A Average Price (USD/Pcs) & (2020-2031)

Figure 18. Alpha Galactosidase A Report Years Considered

Figure 19. Alpha Galactosidase A Sales Share by Manufacturers in 2024

Figure 20. Global Alpha Galactosidase A Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Alpha Galactosidase A Players: Market Share by Revenue in Alpha Galactosidase A in 2024

Figure 22. Alpha Galactosidase A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Alpha Galactosidase A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Alpha Galactosidase A Sales Market Share by Country (2020-2031)

Figure 25. North America Alpha Galactosidase A Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Alpha Galactosidase A Sales Market Share by Country (2020-2031)

Figure 29. Europe Alpha Galactosidase A Revenue Market Share by Country (2020-2031)

Figure 30. Germany Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Alpha Galactosidase A Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Alpha Galactosidase A Revenue Market Share by Region (2020-2031)

Figure 37. China Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Alpha Galactosidase A Sales Market Share by Country (2020-2031)

Figure 48. Latin America Alpha Galactosidase A Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Alpha Galactosidase A Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Alpha Galactosidase A Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Alpha Galactosidase A Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Alpha Galactosidase A by Type (2020-2031)

Figure 58. Global Revenue Market Share of Alpha Galactosidase A by Type (2020-2031)

Figure 59. Global Alpha Galactosidase A Price (USD/Pcs) by Type (2020-2031)

Figure 60. Global Sales Market Share of Alpha Galactosidase A by Application (2020-2031)

Figure 61. Global Revenue Market Share of Alpha Galactosidase A by Application (2020-2031)

Figure 62. Global Alpha Galactosidase A Price (USD/Pcs) by Application (2020-2031)

Figure 63. Alpha Galactosidase A Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Alpha Galactosidase A Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-25P2878

Global Alpha Galactosidase A Market Research Report 2025

FEATURED COMPANIES

Alpha Galactosidase A Market

Report Scope

Scope of Alpha Galactosidase A Market Report

Core Chapters

FAQ for this report

Who are the main players in the Alpha Galactosidase A Market report?

What are the Application segmentation covered in the Alpha Galactosidase A Market report?

What are the Type segmentation covered in the Alpha Galactosidase A Market report?

FEATURED COMPANIES

RELATED REPORTS